A New Track Ablation Device for Liver Biopsy: A Feasibility Study

NCT02521129 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Liver Neoplasms

Interventions

DEVICE: Biopsy Track Ablator (STARmed, Goyang, Korea)

Sponsor

Samsung Medical Center